The European Commission (EC) has granted approval for tislelizumab (Tevimbra) as a combination treatment for adults with resectable non-small cell lung cancer (NSCLC) at high risk...
President Donald Trump embarked on a visit to Scotland on Friday, combining presidential duties with personal business interests. This trip includes a weekend golf outing at...
